IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 33 filers reported holding IMPEL NEUROPHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,020 | -70.4% | 16,325 | -12.4% | 0.01% | -68.8% |
Q2 2023 | $23,680 | -9.3% | 18,646 | 0.0% | 0.02% | -11.1% |
Q1 2023 | $26,104 | -62.7% | 18,646 | 0.0% | 0.02% | -61.7% |
Q4 2022 | $69,923 | -23.2% | 18,646 | 0.0% | 0.05% | -16.1% |
Q3 2022 | $91,000 | -47.7% | 18,646 | 0.0% | 0.06% | -47.7% |
Q2 2022 | $174,000 | +46.2% | 18,646 | 0.0% | 0.11% | +67.2% |
Q1 2022 | $119,000 | -26.1% | 18,646 | 0.0% | 0.06% | -25.6% |
Q4 2021 | $161,000 | – | 18,646 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 2,759,791 | $340,834 | 0.05% |
ST GERMAIN D J CO INC | 1,500 | $185 | 0.00% |